Cargando…
Pioglitazone Improves Reversal Learning and Exerts Mixed Cerebrovascular Effects in a Mouse Model of Alzheimer’s Disease with Combined Amyloid-β and Cerebrovascular Pathology
Animal models of Alzheimer’s disease (AD) are invaluable in dissecting the pathogenic mechanisms and assessing the efficacy of potential new therapies. Here, we used the peroxisome proliferator-activated receptor gamma agonist pioglitazone in an attempt to rescue the pathogenic phenotype in adult (1...
Autores principales: | Papadopoulos, Panayiota, Rosa-Neto, Pedro, Rochford, Joseph, Hamel, Edith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715495/ https://www.ncbi.nlm.nih.gov/pubmed/23874687 http://dx.doi.org/10.1371/journal.pone.0068612 |
Ejemplares similares
-
Cerebrovascular pathology in Down syndrome and Alzheimer disease
por: Head, Elizabeth, et al.
Publicado: (2017) -
Imaging of cerebrovascular pathology in animal models of Alzheimer's disease
por: Klohs, Jan, et al.
Publicado: (2014) -
Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease
por: Bryant, Annie G., et al.
Publicado: (2020) -
Cerebrovascular disease promotes tau pathology in Alzheimer’s disease
por: Laing, Krystal K, et al.
Publicado: (2020) -
Alzheimer's disease and cerebrovascular pathology alter inward rectifier potassium (K(IR)2.1) channels in endothelium of mouse cerebral arteries
por: Lacalle‐Aurioles, María, et al.
Publicado: (2022)